Expanded Intellia CRISPR data set up showdown with Pfizer, Ionis and Alnylam in not-so-rare disease - Endpoints News
2/28/2022 12:00:00 AM3 years 2 months ago
by Jason Mast
by Jason Mast
Eight months after delivering landmark results with one of the first CRISPR clinical trials of its kind, Intellia announced the experimental therapy held up in a larger group of patients and over a longer period of time. In the initial study, Intellia showed …
Eight months after delivering landmark results with one of the first CRISPR clinical trials of its kind, Intellia announced the experimental therapy held up in a larger group of patients and over a l… [+5802 chars]
full article...